6612.TWO · ICARES
Taiwan · RS rating 70 · As of 2026-10-08
| Price | 71.90 TWD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 64 / 78 / 30 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 34 / 41 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -11.1% |
| Sales growth Q/Q | +16.4% |
| Distance from 52-week high | +17.1% |
| Market cap (USD) | $124.3M |